191 related articles for article (PubMed ID: 34003395)
1. Cytokines in the Treatment of Melanoma.
Bentebibel SE; Diab A
Curr Oncol Rep; 2021 May; 23(7):83. PubMed ID: 34003395
[TBL] [Abstract][Full Text] [Related]
2. Interferon, interleukin-2, and other cytokines.
Buchbinder EI; McDermott DF
Hematol Oncol Clin North Am; 2014 Jun; 28(3):571-83. PubMed ID: 24880948
[TBL] [Abstract][Full Text] [Related]
3. Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.
Naing A; Papadopoulos KP; Autio KA; Ott PA; Patel MR; Wong DJ; Falchook GS; Pant S; Whiteside M; Rasco DR; Mumm JB; Chan IH; Bendell JC; Bauer TM; Colen RR; Hong DS; Van Vlasselaer P; Tannir NM; Oft M; Infante JR
J Clin Oncol; 2016 Oct; 34(29):3562-3569. PubMed ID: 27528724
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of cytokines in the treatment of advanced melanoma. For the EORTC Melanoma Cooperative Group.
Keilholz U; Eggermont AM
Oncology; 2000 Feb; 58(2):89-95. PubMed ID: 10705235
[TBL] [Abstract][Full Text] [Related]
5. Cytokine therapy in advanced melanoma.
Kalaaji AN
J Drugs Dermatol; 2007 Apr; 6(4):374-8. PubMed ID: 17668534
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy, cytokines, and biochemotherapy for melanoma.
Eton O
Cancer Chemother Biol Response Modif; 2005; 22():739-48. PubMed ID: 16110637
[No Abstract] [Full Text] [Related]
7. Cytokines as potential combination agents with PD-1/PD-L1 blockade for cancer treatment.
Rahimi Kalateh Shah Mohammad G; Ghahremanloo A; Soltani A; Fathi E; Hashemy SI
J Cell Physiol; 2020 Jul; 235(7-8):5449-5460. PubMed ID: 31970790
[TBL] [Abstract][Full Text] [Related]
8. Biochemotherapy of melanoma.
Keilholz U
Forum (Genova); 2003; 13(2):158-65; quiz 189. PubMed ID: 14732882
[TBL] [Abstract][Full Text] [Related]
9. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12.
Floros T; Tarhini AA
Semin Oncol; 2015 Aug; 42(4):539-48. PubMed ID: 26320059
[TBL] [Abstract][Full Text] [Related]
10. The IL-2 cytokine family in cancer immunotherapy.
Sim GC; Radvanyi L
Cytokine Growth Factor Rev; 2014 Aug; 25(4):377-90. PubMed ID: 25200249
[TBL] [Abstract][Full Text] [Related]
11. Unexpected cytokines in serum of malignant melanoma patients during sequential biochemotherapy.
Grimm EA; Smid CM; Lee JJ; Tseng CH; Eton O; Buzaid AC
Clin Cancer Res; 2000 Oct; 6(10):3895-903. PubMed ID: 11051235
[TBL] [Abstract][Full Text] [Related]
12. [Cytokines: current status and prospects in the treatment of skin tumors].
Nashan D; Luger TA
Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
[TBL] [Abstract][Full Text] [Related]
13. Biologic therapy of melanoma with cytokines and lymphocytes.
Bear HD; Hamad GG; Kostuchenko PJ
Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
[TBL] [Abstract][Full Text] [Related]
14. Biochemotherapy for advanced melanoma.
Keilholz U; Gore ME
Semin Oncol; 2002 Oct; 29(5):456-61. PubMed ID: 12407510
[TBL] [Abstract][Full Text] [Related]
15. Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha.
Legha SS; Ring S; Bedikian A; Plager C; Eton O; Buzaid AC; Papadopoulos N
Ann Oncol; 1996 Oct; 7(8):827-35. PubMed ID: 8922197
[TBL] [Abstract][Full Text] [Related]
16. Cytokine therapy of malignant melanoma.
Villikka K; Pyrhönen S
Ann Med; 1996 Jun; 28(3):227-33. PubMed ID: 8811166
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials.
Keilholz U; Scheibenbogen C; Tilgen W; Bergmann L; Weidmann E; Seither E; Richter M; Brado B; Mitrou PS; Hunstein W
Cancer; 1993 Jul; 72(2):607-14. PubMed ID: 8319195
[TBL] [Abstract][Full Text] [Related]
18. Cytokines in the Treatment of Cancer.
Conlon KC; Miljkovic MD; Waldmann TA
J Interferon Cytokine Res; 2019 Jan; 39(1):6-21. PubMed ID: 29889594
[TBL] [Abstract][Full Text] [Related]
19. Role of interferons in the therapy of melanoma.
Kirkwood JM; Ernstoff MS
J Invest Dermatol; 1990 Dec; 95(6 Suppl):180S-184S. PubMed ID: 1701805
[TBL] [Abstract][Full Text] [Related]
20. Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
Sharma M; Khong H; Fa'ak F; Bentebibel SE; Janssen LME; Chesson BC; Creasy CA; Forget MA; Kahn LMS; Pazdrak B; Karki B; Hailemichael Y; Singh M; Vianden C; Vennam S; Bharadwaj U; Tweardy DJ; Haymaker C; Bernatchez C; Huang S; Rajapakshe K; Coarfa C; Hurwitz ME; Sznol M; Hwu P; Hoch U; Addepalli M; Charych DH; Zalevsky J; Diab A; Overwijk WW
Nat Commun; 2020 Jan; 11(1):661. PubMed ID: 32005826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
